News

UNC Research Contributes to FDA Approval of New Drug for Rare Genetic Disorder

A clinical trial at UNC led by Joseph Muenzer, MD, PhD, paves the way for a first-of-its-kind treatment that can slow the progression of Hunter syndrome. A drug tested in a clinical trial at UNC, led by renowned UNC pediatric biochemical geneticist Joseph Muenzer, MD, PhD, has been approved by the U.S. Food and Drug … Read more

Modeling the lung in the lab

Elizabeth Corteselli used an NC TraCS pilot grant to create a new model for studying lung diseases and potential treatments. For most of us, breathing is something we take for granted. Multiple times per minute, all day and every day, we inhale, gathering the oxygen we rely on, and exhale, releasing carbon dioxide and other … Read more

Renowned UNC Pediatric Biochemical Geneticist Leads First Study on a Novel Treatment for Hunter Syndrome

Joseph Muenzer, MD, PhD, leads research on groundbreaking therapy that offers hope for ultra-rare disease patients across the world living with a devastating genetic disorder. Ongoing clinical research at UNC could lead to a first-of-its-kind enzyme replacement therapy for Hunter syndrome, an ultra-rare disorder that causes progressive multisystem disease and neurologic decline.

UNC Awarded Funding To Implement Useful Research Results to Prevent Childhood Obesity

This project is co-led by Dual Principal Investigators Dr. Kori Flower at the University of North Carolina at Chapel Hill and Dr. Eliana Perrin at The Johns Hopkins University. We are pleased to announce that the University of North Carolina at Chapel Hill has been approved for funding by the Patient-Centered Outcomes Research Institute (PCORI) … Read more